Fortress Biotech, Inc. (FBIO) vs MindWalk Holdings Corp. (HYFT)

Fortress Biotech, Inc. and MindWalk Holdings Corp. are both Biotechnology companies. Fortress Biotech, Inc. and MindWalk Holdings Corp. are of similar size ($66.0M and $63.7M). MindWalk Holdings Corp. has negative trailing earnings, so its P/E is not meaningful; Fortress Biotech, Inc. trades at 0.6×. Fortress Biotech, Inc. grew revenue faster over the last twelve months: 15.5% against −27.0%. Fortress Biotech, Inc. has the higher net margin (151.0% vs −105.1%) and the higher return on invested capital (−41.3% vs −464.6%). Across the 18 metrics below, Fortress Biotech, Inc. leads on 18 and MindWalk Holdings Corp. on 0.

Valuation

Metric FBIO HYFT Biotechnology median
P/E 0.57 n/m 8.50
P/S 0.87 5.23 9.71
P/B 0.29 12.39 2.13
Price to free cash flow 0.69 n/m 20.82
EV/EBITDA 4.86 n/m 0.64
EV/Sales (1.44) 5.14 9.21
Earnings yield 174.33% (19.85%) (33.15%)
Free cash flow yield 144.39% (14.68%) (25.50%)

Profitability

Metric FBIO HYFT Biotechnology median
Gross margin 65.59% 60.81% 65.16%
Operating margin (42.61%) (103.99%) 0.00%
Net margin 150.98% (105.06%) 0.00%
Free cash flow margin 183.80% (76.79%) 0.00%
Return on equity 84.91% (122.85%) (56.36%)
Return on assets 43.38% (58.55%) (48.04%)
Return on invested capital (41.34%) (464.59%) 0.00%

Growth

Metric FBIO HYFT Biotechnology median
Revenue growth (TTM) 15.46% (26.99%) 6.02%
EPS growth (last fiscal year) 97.40% 66.15% 30.26%
Revenue growth, 5-year CAGR 6.77% (3.83%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric FBIO HYFT Biotechnology median
Debt to equity 0.17 0.43 0.00
Current ratio 3.96 1.84 4.72
Net debt to EBITDA 0.43 0.62 0.96

Dividend

Metric FBIO HYFT Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric FBIO HYFT Biotechnology median
Market cap 63.70m 65.95m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack